维普期刊资源整合服务平台（V6.5）

45篇 您的检索式：作者名="Benz CC"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies 显示文摘	Mattie MD Benz CC Bowers J	2006	MolCancer2006，5，：	1
2	Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast can-cer biopsies显示文摘	Mattie MD Benz CC Bowers J	2006	Mol Cancer2006，5，：	1
3	Estrogen receptor-nega- tive breast cancer is less likely to arise among lipophilic statin users显示文摘	KUMAR AS BENZ CC SHIM V	2008	Cancer Epidemiol Biomarkers Prey2008，17，5：	1
4	Optimized high-throughput microRNA expression profding provides novel biomarker assessment of clinical prostate and breast cancer biopsies 显示文摘	Mattie MD Benz CC Bowers J	2006	Mol Cancer2006，5，：	1
5	Targeting the ets binding site of the HER2/neu promoter with pyrrole-imidazole polyamides显示文摘	Chiang SY Burli RW Benz CC	2000	J Biol Chem2000，275，24：	1
6	Optimized high-throughput microRNA expression profiling provides novel biomarker assess- ment of clinical prostate and breast cancer biopsies 显示文摘	Mattie MD Benz CC Bowers J	2006	Mol Cancer2006，5，：	1
7	Optimized high- throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies显示文摘	Mattle MD Benz CC Bowers J	2006	Mol Cancer2006，5，：	1
8	Estrogen-dependent, tamo- xifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu 显示文摘	Benz CC Scott GK Sarup JC	1992	Breast Cancer Res Treat1992，24，2：	1
9	Optimized high-through put microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies显示文摘	Mattie MD Benz CC Bowers J et a1	2006	Mol Cancer2006，5，：	1
10	Future directions of liposome-and immunoliposome-based cancer therapeutics显示文摘	Park JW Benz CC Martin FJ	2004	Semin Oncol2004，31，613：	1
11	Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies 显示文摘	MaRie MD Benz CC Bowers J	2006	Mol Cancer2006，5，：	1
12	Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies显示文摘	Mattie MD Benz CC Bowers J		0，，：	1
13	Future directions of liposome-and immunoliposome-based cancer therapeutics显示文摘	Park JW Benz CC Martin FJ	2004	Semin Oncol2004，31，6：	1
14	Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers 显示文摘	Yau C Benz CC	2008	Breast Cancer Res2008，10，4：	1
15	Optimized high-throughputmicroRNA expression profiling provides novel biomarkerassessment of clinical prostate and breast cancer biopsies 显示文摘	Mattie MD Benz CC Bowers J	2006	MolCancer2006，5，：	1
16	Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies 显示文摘	Mattie MD Benz CC Bowers J	2006	Mol Cancer2006，5，：	1
17	Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies显示文摘	Mattie MD Benz CC BowersJ	2006	Mol Cancer2006，5，：	1
18	Detection of amplified oncogenes by differectial palymerase chain Reaction 显示文摘	Frye RA Benz CC Liu E	1989	Oncogene1989，4，9：	1
19	Uture directions of liposome-and immunoliposome-based cancer therapeutics显示文摘	Park JW Benz CC Martin FJ	2004	Semin Oncol2004，31，613：	1
20	Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu显示文摘	Benz CC Scott GK Sarup JC	1992	Breast Cancer Res Treat1992，24，2：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示